Geron: Pay

Geron paid its 8 named executives $30.0M in total in FY2025 (Dec). CEO Harout Semerjian was paid $10.2M of that.

Pay$100 in the stock at the end of FY21 → $40
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Harout SemerjianPresident and Chief Executive Officer (as of August 7, 2025)
FY2025 (Dec)
1 year
John A. Scarlett, M.D.Former Chairman of the Board, President and Chief Executive Officer
FY2025 (Dec)Not disclosed
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Andrew J. Grethlein, Ph.D.Former Executive Vice President, Chief Operating Officer
FY2025 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
3 years
Ahmed ElNawawiExecutive Vice President, Chief Commercial Officer (as of October 20, 2025)
FY2025 (Dec)
1 year
James ZieglerFormer Executive Vice President, Chief Commercial Officer (as of September 9, 2024)
FY2025 (Dec)Not disclosed
1 year
Michelle RobertsonExecutive Vice President, Finance, Chief Financial Officer, Treasurer and Interim Secretary
FY2025 (Dec)Not disclosed
FY2024 (Dec)
FY2023 (Dec)Not disclosed
3 years
Joseph Eid, M.D.Executive Vice President, Research & Development, Chief Medical Officer (as of November 11, 2024)
FY2025 (Dec)Not disclosed
1 year
Dawn Carter BirFormer Interim President and Chief Executive Officer (as of March 17, 2025)
FY2025 (Dec)
1 year

CEO pay against the pay peers

No CEO pay of the disclosed peers is on file for FY2024 (Dec).

  1. 1GeronNot disclosed
  2. 21. ADMA Biologics, Inc.Not disclosed
  3. 310. ImmunoGen, Inc.Not disclosed
  4. 411. Krystal Biotech, Inc.Not disclosed
  5. 512. MannKind CorporationNot disclosed
  6. 613. Mirum Pharmaceuticals, Inc.Not disclosed
  7. 714. Revance Therapeutics, Inc.Not disclosed
  8. 815. Rhythm Pharmaceuticals, Inc.Not disclosed
  9. 916. Seres Therapeutics, Inc.Not disclosed
  10. 1017. SpringWorks Therapeutics, Inc.Not disclosed
  11. 1118. TG Therapeutics, Inc.Not disclosed
  12. 1219. Travere Therapeutics, Inc.Not disclosed
  13. 132. Amylyx Pharmaceuticals, Inc.Not disclosed
  14. 1420. Veracyte, Inc.Not disclosed
  15. 1521. Vericel Corp.Not disclosed
  16. 163. Ardelyx, Inc.Not disclosed
  17. 174. Catalyst Pharmaceuticals, Inc.Not disclosed
  18. 185. Coherus Biosciences, Inc.Not disclosed
  19. 196. Cytokinetics, Inc.Not disclosed
  20. 207. Day One Biopharmaceuticals, Inc.Not disclosed
  21. 218. Deciphera Pharmaceuticals, Inc.Not disclosed
  22. 229. ImmunityBio, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.